CUSTOMER SUPPORT
  • Home
  • Products
  • Software
  • Lung Texture Analysis™

SaaS Software

LTA™

Transform a standard chest CT into a detailed map of ILA lung textures

LTA™ (Lung Texture Analysis) is based on the highly regarded CALIPER technology pioneered at the Mayo Clinic, LTA provides visualization and quantification of the lung textures that are key to identifying Interstitial Lung Diseases (ILD’s) and other fibrotic conditions (normal, ground glass, reticular, honeycomb and hyperlucent).

ARTG Approved, CE Mark Certified, Health Canada Approved, Investigational Use Only in the U.S.

The Power of Personalized Quantitative Imaging

LTA provides an intuitive texture overlay on the patient scan to highlight abnormalities and increase diagnostic confidence and includes a detailed physician report of each patient analysis.

Rapid, Automated Inspiration-only Processing
Rapid, Automated Inspiration-only Processing
LTA’s DICOM image series provides an intuitive texture overlay on the patient scan to highlight abnormalities and increase diagnostic confidence.
LTA Physician Summary Report
LTA Physician Summary Report
LTA’s outputs include an automated report showing detailed quantification of the lung textures by region using color-coded overlays to help reduce reading variation, and enable data-based decisions for drug therapy, clinical procedures and other personalized patient care.

For Your Practice

Lung Texture Analysis™

Aiding ILD specialists. High-resolution CT (HRCT) is a vital diagnostic tool for fibrotic conditions. Diagnostic accuracy is essential for optimal patient care decisions, but readers often disagree. Even with modern HRCT, imaging diagnosis remains challenging. Studies show that diagnostic accuracy for ILD’s varies greatly between readers and there is poor agreement among physicians in noting findings on CT imaging indicative of fibrotic conditions.

LTA is effective in the classification of normal versus abnormal tissue and performs as well as the experts in distinguishing among typical pathologies present in lungs with fibrotic disease.

Suggested use cases for LTA

  • Aiding ILD diagnosis and therapy response assessment
  • Population screening for ILD/ILA/UIP/IPF
  • Lung Cancer Screening Programs
  • Lung Health Programs

    Imbio, a fully owned subsidiary of 4DMedical, is the legal manufacturer of LTA

     

    What's new at 4DMedical

    Get the latest news about respiratory imaging and ventilation analysis
    CUSTOMER SUPPORT